This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UTX vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UTX vs. DHR: Which Stock Is the Better Value Option?
Is Danaher (DHR) Stock Outpacing Its Conglomerates Peers This Year?
by Zacks Equity Research
Is (DHR) Outperforming Other Conglomerates Stocks This Year?
ITT's Q2 Earnings and Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
ITT's second-quarter earnings and revenues rise year over year on the back of solid performance across Industrial Process and Connect & Control Technologies segments.
Macquarie Infrastructure's (MIC) Q2 Earnings Decline Y/Y
by Zacks Equity Research
Macquarie Infrastructure's (MIC) second-quarter earnings decline year over year on account of higher selling, general and administrative and depreciation costs and rise in interest expenses.
General Electric (GE) Beats Q2 Earnings Estimates, Ups View
by Zacks Equity Research
General Electric's (GE) second-quarter 2019 earnings decline year over year due to weakness in sales and margins. However, earnings beat estimates by 41.7%. It raises earnings view for 2019.
3M (MMM) Q2 Earnings and Sales Beat Estimates, Down Y/Y
by Zacks Equity Research
3M's (MMM) second-quarter 2019 results suffer from forex woes, adverse impact of divestitures and weak organic sales. However, its earnings and sales surpass respective estimates.
Carlisle (CSL) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Carlisle's (CSL) second-quarter 2019 results benefit from growth in organic sales, acquired assets and margin improvement.
United Technologies' (UTX) Q2 Earnings and Revenues Beat
by Zacks Equity Research
United Technologies' (UTX) Q2 earnings jump year over year on the back of solid performance across most of its segments.
Crane (CR) Beats Earnings Estimates in Q2, Declares Dividend
by Zacks Equity Research
Crane's (CR) second-quarter 2019 results gain from a decline in costs and expenses, and hence, better margin profile. It declares a dividend to be paid in September.
CR vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CR vs. DHR: Which Stock Is the Better Value Option?
Is Danaher (DHR) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Danaher (DHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Danaher (DHR) Beats on Q2 Earnings and Sales, Ups Guidance
by Zacks Equity Research
Danaher's (DHR) second-quarter 2019 results benefit from growth in organic sales, acquired assets and DBS initiatives. Furthermore, the company raises its projection for the current year.
Honeywell (HON) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Impressive traction of long-cycle businesses in defense, commercial aerospace, process automation and building technologies drives Honeywell's (HON) Q2 results.
Danaher (DHR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 3.48% and 1.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
Will Danaher's (DHR) Products & Buyouts Drive Q2 Earnings?
by Zacks Equity Research
Danaher (DHR) might gain from healthy demand for products, solid execution, acquired assets and Danaher Business System in the second quarter of 2019. Forex woes remain concerning.
Top Research Reports for Berkshire Hathaway, Pfizer & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Pfizer (PFE) and Danaher (DHR).
Danaher (DHR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
Here's Why it is Worth Buying General Electric (GE) Stock Now
by Zacks Equity Research
General Electric (GE) is likely to gain from restructuring efforts, organic growth opportunities in some segments, reduction of debt levels and expansion in emerging markets.
Danaher (DHR) Names New Dental Company Envista Holdings
by Zacks Equity Research
Danaher (DHR) plans to create a separate dental company Envista, which will be listed on the New York Stock Exchange, and is likely to employ 12,000 people globally.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, salesforce, Danaher, Halliburton and American Airlines
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, salesforce, Danaher, Halliburton and American Airlines
Here's Why it is Worth Holding on to Danaher (DHR) Stock Now
by Zacks Equity Research
Danaher (DHR) stands to gain from solid product portfolio, acquisitive nature and shareholder-friendly policy. High costs and debts as well as forex woes remain concerning.
Top Stock Reports for Berkshire Hathaway, salesforce & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), salesforce (CRM) and Danaher (DHR).